Who owns SYNTHETIC BIOLOGICS INC?
- Ticker: TOVX
- CUSIP Number: 87164u409
Tip: Access positions for across all investors
Analyze quarterly positions in Synthetic Biologics with up to 7 years of data, all consolidated into one spreadsheet
Download as csv Download as ExcelTop investors of Synthetic Biologics stock
Who bought or sold SYNTHETIC BIOLOGICS INC this quarter?
Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
---|---|---|---|---|---|
Vanguard Group | 225k | $106k | -39% | Mar 2024 |
|
BlackRock | 189k | $89k | -1% | Mar 2024 |
|
Geode Capital Management | 141k | $66k | 0% | Mar 2024 |
|
Northern Trust | 27k | $13k | 0% | Mar 2024 |
|
Citadel Advisors | 25k | $12k | -57% | Mar 2024 |
|
Two Sigma Securities | 21k | $10k | 100% | Mar 2024 |
|
Charles Schwab Investment Management | 14k | $6.4k | 0% | Mar 2024 |
|
Lincoln National | 11k | $5.2k | 0% | Mar 2024 |
|
SageView Advisory Group | 10k | $1.0M | 100% | Mar 2024 |
|
William Blair $ Company | 10k | $4.8k | 0% | Mar 2024 |
|
Iron Horse Wealth Management | 365.00 | $171.002500 | 100% | Mar 2024 |
|
IFP Advisors | 296.00 | $127.013600 | -23% | Dec 2023 |
|
Wells Fargo & Company | 233.00 | $109.510000 | 1% | Mar 2024 |
|
Tower Research Capital | 145.00 | $68.005000 | 0% | Mar 2024 |
|
Old Point Trust & Financial Services N A | 100.00 | $47.000000 | 100% | Mar 2024 |
|
Advisor Group Holdings | 47.00 | $20.999600 | 0% | Mar 2024 |
|
Morgan Stanley | 15.00 | $7.000500 | 50% | Mar 2024 |
|
Steward Partners Investment Advisory | 14.00 | $7.000000 | 0% | Mar 2024 |
|
FMR | 10.00 | $5.000000 | -90% | Mar 2024 |
|
Royal Bank of Canada | 9.00 | $0 | 29% | Mar 2024 |
|
Bank of America Corporation | 6.00 | $3.000000 | 0% | Mar 2024 |
|
UBS Group | 3.00 | $0.999900 | 0% | Mar 2024 |
|
Who sold out of Synthetic Biologics?
Fund or Company Name | Date Sold | Shares Held | Valued At |
---|---|---|---|
Jane Street | Dec 2023 | 48k | $21k |
Virtu Financial | Dec 2023 | 39k | $17k |
Bridgeway Capital Management | Sep 2023 | 29k | $15k |